AZD7442 utilization for Pre-Exposure Prophylaxis Against COVID-19 in a French Early Access Program

被引:0
|
作者
Artaud, C. [1 ]
Majed, L. [1 ]
Fabry-Vendrand, C. [1 ]
Taylor, S. [2 ]
Ferreira, C. [3 ]
Dube, S. [2 ]
Thabut, G. [1 ]
Suau, D. [1 ]
Lahouegue, A. [1 ]
机构
[1] AstraZeneca, Courbevoie, France
[2] AstraZeneca, Cambridge, England
[3] AstraZeneca, Wilmington, DE USA
来源
关键词
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
ckad160.97
引用
收藏
页数:2
相关论文
共 50 条
  • [21] HIV pre-exposure prophylaxis (PrEP) during the COVID-19 pandemic
    Uhrmacher, Mona
    Ahaus, Patrick
    Skaletz-Rorowski, Adriane
    Kayser, Arne
    Nambiar, Sandeep
    Brockmeyer, Norbert H.
    Potthoff, Anja
    INFECTION, 2021, 49 (SUPPL 1) : S45 - S46
  • [22] Accelerated cell culture process development and characterization for cilgavimab/tixagevimab (AZD7442) for the prevention and treatment of COVID-19
    Handlogten, Michael W.
    Bosley, Stefanie
    Dunn, Sarah
    Zhu, Jie
    Lee-O'Brien, Allison
    Li, Lina
    Therres, Jamy
    Chakrabarti, Lina
    Khanal, Bijay
    Mowery, Rachel
    Arumugam, Subhashini
    Klover, Judith
    Taleb, Mohammed
    Reier, Jason
    Hatton, Diane
    Schmelzer, Albert
    BIOTECHNOLOGY AND BIOENGINEERING, 2023,
  • [23] Covid-19: AstraZeneca says its antibody drug AZD7442 is effective for preventing and reducing severe illness
    Mahase, Elisabeth
    BMJ-BRITISH MEDICAL JOURNAL, 2021, 375 : n2860
  • [24] SARS-CoV-2 pre-exposure prophylaxis with tixagevimab/cilgavimab (AZD7442) provides protection in inborn errors of immunity with antibody defects: a real-world experience
    Pulvirenti, Federica
    Garzi, Giulia
    Milito, Cinzia
    Sculco, Eleonora
    Sciannamea, Maddalena
    Napoli, Anna
    Cinti, Lilia
    Roberto, Piergiorgio
    Punziano, Alessandra
    Carrabba, Maria
    Piano Mortari, Eva
    Carsetti, Rita
    Antonelli, Guido
    Quinti, Isabella
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [25] Acceptability of a COVID-19 pre-exposure prophylaxis trial with hydroxychloroquine in French healthcare workers during the first wave of COVID-19 pandemic
    Gagneux-Brunon, Amandine
    Schilte, Clementine
    Garcin, Arnauld
    Jolly, Nathalie
    Vray, Muriel
    Schaeffer, Laura
    Duval, Xavier
    Hoen, Bruno
    Botelho-Nevers, Elisabeth
    TRIALS, 2021, 22 (01)
  • [26] Acceptability of a COVID-19 pre-exposure prophylaxis trial with hydroxychloroquine in French healthcare workers during the first wave of COVID-19 pandemic
    Amandine Gagneux-Brunon
    Clémentine Schilte
    Arnauld Garcin
    Nathalie Jolly
    Muriel Vray
    Laura Schaeffer
    Xavier Duval
    Bruno Hoen
    Elisabeth Botelho-Nevers
    Trials, 22
  • [27] Predictors of SARS-CoV-2 Omicron breakthrough infection after receipt of AZD7442 (tixagevimab-cilgavimab) for pre-exposure prophylaxis among hematologic malignancy patients
    Laracy, Justin C.
    Yan, Judy
    Steiger, Samantha N.
    Tan, Carrie A.
    Cohen, Nina
    V. Robilotti, Elizabeth
    Fender, Jerome
    Cohen, Sara
    Korde, Neha
    Lee-Teh, Melissa
    Noy, Ariela
    Oved, Joseph H.
    Roeker, Lindsey E.
    Shah, Gunjan
    Babady, N. Esther
    Kamboj, Mini
    Seo, Susan K.
    HAEMATOLOGICA, 2023, 108 (11) : 3058 - 3067
  • [28] Virtual HIV pre-exposure prophylaxis outpatient service in the era of COVID-19
    Quirke, Siobhan
    Quinn, Laura
    Hegarty, Deborah
    Loy, Aisling
    Lyons, Fiona
    Mulcahy, Fiona
    Devitt, Emma
    INTERNATIONAL JOURNAL OF STD & AIDS, 2021, 32 (01) : 100 - 103
  • [29] Failure of hydroxychloroquine pre-exposure prophylaxis in COVID-19 infection? A case report
    Kauv, Juliette
    Le, Minh P.
    Veyrier, Marc
    Le Hingrat, Quentin
    Visseaux, Benoit
    Massias, Laurent
    Chauveheid, Marie-Paule
    Descamps, Diane
    Ghosn, Jade
    Peytavin, Gilles
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2020, 75 (09) : 2706 - 2707
  • [30] Antimalarials as pre-exposure prophylaxis for COVID-19: A retrospective matched cohort study
    Klebanov, Nikolai
    Pahalyants, Vartan
    Murphy, William S.
    Said, Jordan T.
    Theodosakis, Nicholas
    Duey, Stacey
    Klevens, R. Monina
    Lilly, Evelyn
    Asgari, Maryam
    Semenov, Yevgeniy R.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB131 - AB131